Dario Vignali, PhD, on Immune Resistance Mechanisms in Cancer

February 12, 2020 By The ASCO Post

Dario Vignali, PhD, of the University of Pittsburgh and UPMC Hillman Cancer Center, summarizes his Keynote Address, which covered what drives systemic immune dysfunction in patients with cancer, what promotes inhibitory receptor expression, and what limits the persistence of antigen-specific T cells.

Related Content